Contract sterilisation organisation, Sterigenics International has acquired Toxikon Europe, the company has announced.
Acquisition
Toxikon Europe is the European division of Toxikon Corporation, a Massachusetts-based preclinical contract research organisation. The company provides a suite of integrated analytical, material characterisation and microbiological services to the pharmaceutical, medical device and biologics industries.
Sterigenics International states that the acquisition gives it a more comprehensive service offering and a platform for growth for its Nelson Labs business. Nelson Labs will now offer Toxikon Europe’s extractables and leachables capabilities to its customers around the world.
Michael B. Petras Jr., CEO of Sterigenics International, said: “Toxikon Europe’s geographic foothold and expert analytical testing platform enable our global expansion and ability to provide significantly greater value to customers. We are excited to welcome a strong management team, with over 150 years of aggregate industry experience, and the highly trained Toxikon Europe employees to our company.”
As part of the deal, Nelson Labs and Toxikon USA will enter a long-term supply arrangement under which Nelson Labs will outsource in-vivo biocompatibility to Toxikon USA.
Jeff Nelson, president of Nelson Labs said: “The acquisition of Toxikon Europe and our ongoing partnership with Toxikon USA support our strategy to offer greater breadth of services to meet the demands of our rapidly growing, global customer base. We are now able to serve the pharmaceutical and medical device industries continuously from the early stages of product development through manufacturing, sterilisation, and testing.”
Jos Bollen, managing director, Toxikon Europe, said: “Our customers, who are increasingly focused on quality and safety, will continue to receive the superior service and quality they have come to know from Toxikon Europe. In addition, our breadth of service and our reach will be enhanced with the expertise and industry leadership of Sterigenics International’s Nelson Labs.”
